During the past decade, Centro de Salud la Serreria II conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Centro de Salud la Serreria II" are "Meningococcal Vaccine" (1 trials) and "Pneumococcal Disease" (1 trials). Many other conditions were trialed in "Centro de Salud la Serreria II" in a lesser frequency.

Most popular intervention types in "Centro de Salud la Serreria II" are "Biological" (2 trials), "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "13-valent pneumococcal conjugate vaccine" (1 trials), "20-valent pneumococcal conjugate vaccine" (1 trials), "Bexsero" (1 trials), "Bivalent rLP2086 (120-µg Dose)" (1 trials) and "Bivalent rLP2086 (60-µg Dose)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centro de Salud la Serreria II" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Centro de Salud la Serreria II". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Centro de Salud la Serreria II, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Centro de Salud la Serreria II, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".